New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2014
09:16 EDTRVNC, XRX, GSK, PLXT, BEBE, MCD, LXK, ALSN, FB, HOG, ITW, CMCSA, AGN, NVS, NFLX, FEYE, VRXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
News For AGN;VRX;NFLX;CMCSA;FEYE;NVS;GSK;HOG;MCD;XRX;FB;BEBE;RVNC;ALSN;PLXT;ITW;LXK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
February 19, 2015
07:30 EDTCMCSANBC 'Nightly News' sees drop in ratings post-Brian Williams, WSJ says
Subscribe for More Information
07:12 EDTNVSWharton Health Care Club to hold a conference
Subscribe for More Information
06:17 EDTFBFacebook Seattle gets new office, 1500 hires in 2016, TechFlash says
Subscribe for More Information
05:36 EDTFBFacebook implied volatility of 25 at lower end of index mean range
February 18, 2015
16:46 EDTAGNOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTNFLXOptions Update; February 18, 2015
Subscribe for More Information
12:31 EDTAGNOn The Fly: Midday Wrap
Subscribe for More Information
11:49 EDTFBFacebook CEO would 'love to work with Google' on connectivity, Bloomberg says
Subscribe for More Information
10:33 EDTALSNAllison Transmission management to meet with Oppenheimer
Subscribe for More Information
09:48 EDTAGNActavis Q4 'exceptional,' taking Allergan name 'wise,' says BMO Capital
BMO Capital says Actavis (ACT) is "firing on all cylinders" after reporting "exceptional" Q4 earnings on the strength of the company's North American Generics and International segment. BMO views the decision to adopt the Allergan (AGN) name as "wise" given the Botox maker's strong reputation. The firm keeps an Outperform rating on Actavis.
09:37 EDTNFLXOption volume leaders on open
Option volume leaders: AAPL TSLA TWTR CELG APO NFLX AXP APA LNKD C GILD according to Track Data.
08:27 EDTFBFacebook in talks with media about hosting news content, Re/code says
Facebook is speaking to media publishers about hosting news content "that would otherwise go on a publisher’s own website," reports Re/code, citing statements by Facebook chief product officer Chris Cox at the Code/Media conference. Cox said Facebook could provide a larger audience and improved design, though he noted potential partnerships "aren't coming anytime soon." Additionally, Cox said the company's video efforts have been "a massive success" but the company "isn’t rushing" to pay content creators. Reference Link
07:50 EDTAGNActavis CEO says company gave appropriate guidance to analysts
Actavis (ACT) CEO Saunders said he believes that the company did provide appropriate guidance to analysts ahead of its earnings beat. Saunders sees the Allergan (AGN) deal closing by the end of this quarter or early next quarter. Saunders says tying R&D to a percentage of revenue "makes no sense to me," noting that Actavis will spend about $1.7B on R&D next year. Saunders says will do acquisition if opportunity arises, but not planning for M&A right now. Actavis CEO Brent Saunders is speaking on CNBC.
07:13 EDTCMCSANational Association of Regulatory Utility Commission to hold a meeting
Subscribe for More Information
07:07 EDTITWBarclays to hold a conference
Industrial Select Conference is being held in Miami on February 18-19.
07:01 EDTAGNActavis announces intention to adopt 'Allergan' corporate name
Subscribe for More Information
06:34 EDTAGNActavis sees Allergan transaction completed in late Q1 or early Q2
06:33 EDTCMCSAJAKKS Pacific signs licensing agreement for Universal Pictures franchise
Subscribe for More Information
06:29 EDTFBFacebook engagement data remains strong, says JPMorgan
JPMorgan notes that according to comScore, Facebook’s share of mobile Internet time excluding Instagram and WhatsApp in January was 21%, up from 20% in December, and its share of total Internet time including desktop was 17%. The firm believes the data suggests continued strong engagement for Facebook. It reiterates an Overweight rating on the stock with an $85 price target, calling the stock a favorite idea for 2015.
06:10 EDTFBFacebook is developing virtual reality apps, Re/code says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use